Background illustration for clinical trials search

Pancreatic Cancer Clinical Trials

Browse 1,722 pancreatic cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Padeliporfin VTP Treatment for Unresectable Pancreatic Adenocarcinoma

for
Locally Advanced Unresectable Pancreatic Adenocarcinoma
Location: Duarte CA, Irvine CA
Sponsor: Impact Biotech Ltd

Sex: All

Age: 18+

Code: NCT05919238

Phase 1, Recruiting

A First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung Cancer

for
Advanced Solid Tumors, Non-Small Cell Lung Cancer
Location: Ohio City OH
Sponsor: Chong Kun Dang Pharmaceutical

Sex: All

Age: 19+

Code: NCT07439094

Phase 1, Phase 2, Recruiting

Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease

for
Chest Wall Tumor, Breast Cancer, Lung Cancer, Esophageal Cancer,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07685938

Phase 2, Recruiting

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

for
Advanced Solid Tumor, Diffuse Large B Cell Lymphoma,
Location: Boston MA, Philadelphia PA, Charlottesville VA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT04104776

Phase 1, Phase 2, Recruiting

A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors

for
Solid Tumor, Renal Cell Cancer Metastatic,
Location: Philadelphia PA, Dallas TX
Sponsor: Eutilex

Sex: All

Age: 18+

Code: NCT04903873

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

for
Advanced Solid Tumor Cancer
Location: Boston MA, Providence RI, New Haven CT, New York NY,
Sponsor: Calico Life Sciences LLC

Sex: All

Age: 18+

Code: NCT04777994

Phase 1, Recruiting

Wearable Devices and Biomarkers Project (Healthiomics)

for
Brain Cancer, Neurological Disorder, Neurological Cancer
Location: San Diego CA
Sponsor: CureScience

Sex: All

Age: 18+

Code: NCT05106725

Recruiting

Endoscopic Resection Multicenter Registry

for
Gastrointestinal Neoplasms, Gastrointestinal Disease,
Location: New York NY
Sponsor: Weill Medical College of Cornell University

Sex: All

Age: 18+

Code: NCT03065257

Recruiting

Regenecare® Wound Gel in Treating Rash in Patients Receiving Cetuximab or Other Epidermal Growth Factor Receptor Inhibitor Therapy for Cancer

for
Dermatologic Complications,
Location: Harvey IL
Sponsor: Ingalls Memorial Hospital

Sex: All

Age: 18+

Code: NCT00498992

Recruiting

Physician Perceptions About Parenteral Hydration in Latin America and Spain

for
Dehydration, Advanced Cancers
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT01011140

Recruiting

A Phase 1 Study of IM-1021 in Participants With Advanced Cancer

for
Solid Malignancies, Hematologic Malignancies
Location: Providence RI, New Haven CT, Charlottesville VA,
Sponsor: Immunome, Inc.

Sex: All

Age: 18+

Code: NCT06823167

Phase 1, Recruiting

Collection and Distribution of Biospecimens for Novel Research Uses

for
Cancer, Healthy, Gastrointestinal Complication,
Location: Huntsville AL
Sponsor: iSpecimen Inc

Sex: All

Age: 0 - 70+

Code: NCT03848962

Recruiting

A Modular Phase 1/2 Study With CT7439 in Participants With Solid Malignancies

for
Solid Malignancies
Location: Fairfax VA, Dallas TX, San Antonio TX
Sponsor: Carrick Therapeutics Limited

Sex: All

Age: 18+

Code: NCT06600789

Phase 1, Phase 2, Recruiting

Arizona Cancer Center Biospecimen Repository

for
Cancer
Location: Tucson AZ
Sponsor: University of Arizona

Sex: All

Age: 18+

Code: NCT00896935

Recruiting

Molecular Testing of Cancer by Integrated Genomic, Transcriptomic, and Proteomic Analysis

for
Solid Tumors, Hematological Malignancies
Location: Providence RI, East Greenwich RI
Sponsor: Rhode Island Hospital

Sex: All

Age: 18+

Code: NCT02213822

Recruiting

Safety, Tolerability, and Pharmacokinetics of DCR-PDL1 in Adults With Solid Tumors

for
Solid Tumors, Adult
Location: Irving TX, San Antonio TX
Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company

Sex: All

Age: 18+

Code: NCT06504368

Phase 1, Recruiting

Study of TBX-3400 in Subjects With Solid Malignant Tumors Resistant or Refractory to Standard Therapies

for
Cancer, Tumor, Solid, Refractory Cancer
Location: Los Angeles CA
Sponsor: Taiga Biotechnologies, Inc.

Sex: All

Age: 18+

Code: NCT04640246

Phase 1, Phase 2, Recruiting

Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells

for
Breast Cancer, Relapse, Resistant Cancer,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06347068

Phase 1, Recruiting

Radiation Therapy in Treating Patients Who Are Undergoing Surgery to Remove a Metastatic Brain Tumor

for
Metastatic Cancer
Location: Cleveland OH
Sponsor: The Cleveland Clinic

Sex: All

Age: 18+

Code: NCT00107367

Phase 1, Phase 2, Recruiting

A Pharmacokinetic Study of Actinomycin-D and Vincristine in Children With Cancer

for
Cancer
Location: Philadelphia PA
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Sex: All

Age: 0 - 18

Code: NCT00491946

Recruiting

What is pancreatic cancer?

The pancreas sits deep behind the stomach and makes both digestive enzymes and hormones like insulin. About 92 percent of pancreatic cancers start in the enzyme making cells, and this page is mostly about those. The other 8 percent are neuroendocrine tumors, which grow more slowly, have their own trials, and a five year survival of 72 percent against 8 percent. The pancreas gives no early warning. Jaundice, back pain, weight loss and new diabetes usually appear only after the cancer has grown or spread, and fewer than 20 percent of people can have surgery at diagnosis.

Smoking roughly doubles the risk, and type 2 diabetes, extra weight, chronic pancreatitis and family history raise it. About 10 percent of cases come from inherited mutations, so guidelines now recommend genetic testing for everyone diagnosed. That can change treatment and flag relatives who should be watched. The hope comes from biology. More than 90 percent of pancreatic cancers carry a KRAS mutation. That target was called undruggable for decades. Now several RAS inhibitors are in trials, with the first Phase 3 studies recruiting. Pancreatic cancer shares risk factors with type 2 diabetes and inherited genes with breast and ovarian cancer.

Article preview image

Our guide to new treatments for pancreatic cancer covers what has been approved and what is being tested.

Research Paving The Way To A New Treatment For Pancreatic Cancer

Types of pancreatic cancer clinical trials

Who can participate in pancreatic cancer clinical trials?

What causes pancreatic cancer?

The stages of pancreatic cancer, and why they matter for trials

How to enroll in a pancreatic cancer clinical trial